Effect of Paracetamol,Pregabalin and Dexamethasone on Pain and Opioid Requirements in Postoperative Patients

Sponsor
Glostrup University Hospital, Copenhagen (Other)
Overall Status
Completed
CT.gov ID
NCT00209495
Collaborator
(none)
130
2
3
32
65
2

Study Details

Study Description

Brief Summary

Women scheduled for abdominal hysterectomy needs postoperative pain treatment, i.e. morphine. Unfortunately morphine has side-effect: nausea, vomiting, sedation and dizziness, which is unpleasant for the patients and sometimes keeps them at bed longer time than needed. We investigate in new combinations of analgesics for postoperative pain, hoping to minimize the need for morphine.

Condition or Disease Intervention/Treatment Phase
  • Drug: Pregabalin; Dexamethasone
Phase 4

Detailed Description

Combinations of paracetamol versus paracetamol + pregabalin versus paracetamol + pregabalin + dexamethasone is investigated. Primary outcome is 24 hours morphine usage.

Study Design

Study Type:
Interventional
Actual Enrollment :
130 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Official Title:
Effect of Paracetamol Versus Paracetamol Combined With Pregabalin Versus Paracetamol Combined With Pregabalin and Dexamethasone on Pain and Opioid Requirements in Patients Scheduled for Abdominal Hysterectomy.
Study Start Date :
Jun 1, 2005
Actual Primary Completion Date :
Nov 1, 2007
Actual Study Completion Date :
Feb 1, 2008

Arms and Interventions

Arm Intervention/Treatment
Placebo Comparator: A

Drug: Pregabalin; Dexamethasone
Comparing combinations of paracetamol + pregabalin 300 mg + dexamethasone 8 mg

Experimental: B

Pregabalin

Drug: Pregabalin; Dexamethasone
Comparing combinations of paracetamol + pregabalin 300 mg + dexamethasone 8 mg

Experimental: C

Pregabalin + dexamethasone

Drug: Pregabalin; Dexamethasone
Comparing combinations of paracetamol + pregabalin 300 mg + dexamethasone 8 mg

Outcome Measures

Primary Outcome Measures

  1. The total amount of morphine needed postoperatively form 0 - 4 h, and 0 - 24 h, administered by the patient controlled pain treatment. (PCA) [0 - 24h]

Secondary Outcome Measures

  1. Pain Score (VAS) at rest and at mobilisation. [0 - 24h]

  2. Postoperative nausea and vomiting. [0 - 24h]

  3. Sedation. [0 - 24h]

  4. Dizziness. [0 - 24h]

  5. All measurements are taken at 2, 4 and 24 h postoperatively. [0 - 24h]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 75 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Women scheduled for abdominal hysterectomy, between the age of 18 and 75, ASA 1-2

  • BMI between 18-32.

Exclusion Criteria:
Patients who:
  • Are unable to cooperate

  • Has cancer ovarian

  • Does not speak Danish

  • Has allergy for drugs used in the trial

  • Has drug and medicine abuse

  • Epilepsy

  • Diabetes treated with medicine

  • Chronic pain condition

  • Daily use of antacids or analgesic

  • Known kidney disease

  • Use of antidepressive

Contacts and Locations

Locations

Site City State Country Postal Code
1 Operations og Anæstesiologisk afd. Y, KAS Glostrup Glostrup Copenhagen Denmark 2600
2 Herning Centralsygehus Herning Denmark 7400

Sponsors and Collaborators

  • Glostrup University Hospital, Copenhagen

Investigators

  • Principal Investigator: Ole Mathiesen, MD, Department of Anaesthesiology, Copenhagen University Hospital in Glostrup, 2600 Glostrup, Denmark

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00209495
Other Study ID Numbers:
  • SM1-04
First Posted:
Sep 21, 2005
Last Update Posted:
Feb 29, 2008
Last Verified:
Feb 1, 2008

Study Results

No Results Posted as of Feb 29, 2008